椎体形成術および肝動脈形成術の針市場：手技別、エンドユーザー別-2025-2030年の世界予測

椎体形成術および肝動脈形成術の針市場は、2023年に10億2,000万米ドルと評価され、2024年には11億米ドルに達すると予測され、CAGR 8.23%で成長し、2030年には17億7,000万米ドルになると予測されています。

椎体形成術および骨盤形成術の針は、骨粗鬆症によって引き起こされることの多い椎体圧迫骨折を治療するための低侵襲処置に使用される特殊な医療器具です。これらの針は、骨折した椎骨に骨セメントを注入することで脊柱を安定させ、痛みを和らげ、患者の運動能力を向上させる上で極めて重要です。用途は主にヘルスケア分野、特に病院や外来手術センターで、骨粗鬆症性骨折を起こしやすい高齢者層をターゲットとしています。市場を牽引する主な成長要因としては、骨粗鬆症の罹患率の上昇、低侵襲脊椎手術技術の進歩などが挙げられます。さらに、世界人口の高齢化と脊椎の健康に対する意識の高まりが需要を押し上げています。

医療インフラが整備され、ヘルスケア支出が増加している新興市場にビジネスチャンスがあります。企業はまた、注射針の効率と安全性を高めるための製品開発に投資したり、地理的な足跡を拡大したりすることで、利益を得ることができます。しかし、この市場は、手術費用の高騰、脊椎手術に伴う合併症の可能性、厳しい規制要件といった課題に直面しており、これが成長の妨げとなる可能性があります。

技術革新は、精度を高めるための精密加工針や、手術結果を改善するためのスマート技術の統合など、費用対効果の高いソリューションの開発に重点を置くことができます。生分解性骨セメントや生体活性材料の調査も新たな道を開く可能性があります。競争上の差別化は、カスタマイズを重視し、医療専門家向けのトレーニングを含む包括的なサービスパッケージを提供することで達成できると思われます。

市場競争は中程度で、主要プレーヤーは常に先進的な製品提供と技術的利便性を追求しています。企業はまた、特に安全基準や手続き上の承認に関する規制状況の変化にも留意する必要があります。したがって、企業は技術的進歩やヘルスケアプロバイダーとの提携を活用し、市場への浸透と臨床成果を高める必要があります。

市場力学：急速に進化する椎体形成術および肝動脈形成術の針市場における主要市場インサイトの解明

椎体形成術および肝動脈形成術の針市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口における脊椎損傷の発生率の上昇
  • 世界中で継続するヘルスケア支出
  • 骨折の効率化と安定化に関する意識の高まり
• 市場抑制要因
  • 椎体形成術およびクリフォプラスティ針の高コスト
• 市場機会
  • 椎体形成術および転子形成術用針の技術的進歩
  • 組織間の協力とパートナーシップの構築
• 市場の課題
  • セメントの漏れや隣接骨の骨折に関連する合併症への懸念

ポーターの5つの力：椎体形成術および肝動脈形成術の針市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：椎体形成術および肝動脈形成術の針市場における外部からの影響の把握

外部マクロ環境要因は、椎体形成術および肝動脈形成術の針市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析椎体形成術および肝動脈形成術の針市場における競合情勢の把握

椎体形成術および肝動脈形成術の針市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス椎体形成術および肝動脈形成術の針市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、椎体形成術および肝動脈形成術の針市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨椎体形成術および肝動脈形成術の針市場における成功への道筋を描く

椎体形成術および肝動脈形成術の針市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口における脊髄損傷の発生率の上昇
    • 世界中で進行中のヘルスケア費
    • 手術による骨折の効率と安定化に関する認識の高まり
  • 抑制要因
    • 椎体形成術および眼瞼形成術の針の高コスト
  • 機会
    • 椎体形成術および眼瞼形成術用針の技術的進歩
    • 組織間の新たなコラボレーションとパートナーシップ
  • 課題
    • セメントの漏出や隣接骨の骨折に関連する合併症の懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 椎体形成術および肝動脈形成術の針市場手順別

• 椎体形成術の手順
• 椎体形成術の手順
  • 方向性椎体形成術用針
  • ストレート椎体形成術用針

第7章 椎体形成術および肝動脈形成術の針市場：エンドユーザー別

• 外来手術センター
• 病院

第8章 南北アメリカの椎体形成術および肝動脈形成術の針市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の椎体形成術および肝動脈形成術の針市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの椎体形成術および肝動脈形成術の針市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Becton, Dickinson and Company
• BIOPSYBELL S.R.L.
• Cardinal Health, Inc.
• Globus Medical, Inc.
• IZI Medical Products LLC by Halma PLC
• JAYON IMPLANTS Pvt. Ltd.
• Johnson & Johnson Service, Inc.
• Laurane Medical LLC
• Medtronic PLC
• Merit Medical Systems, Inc.
• Moller Medical GmbH
• Stryker Corporation
• Suretech Medical Inc
• Tecres SPA
• Teknimed

LIST OF FIGURES

• FIGURE 1. VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET RESEARCH PROCESS
• FIGURE 2. VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET DYNAMICS
• TABLE 7. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY KYPHOPLASTY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY DIRECTIONAL VERTEBROPLASTY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY STRAIGHT VERTEBROPLASTY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 27. CANADA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 28. CANADA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CHINA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 44. CHINA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 45. CHINA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. INDIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 47. INDIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 48. INDIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ITALY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 99. ITALY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 100. ITALY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. POLAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 111. POLAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 112. POLAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. QATAR VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 114. QATAR VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 115. QATAR VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY VERTEBROPLASTY PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 144. VERTEBROPLASTY & KYPHOPLASTY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2023

The Vertebroplasty & Kyphoplasty Needles Market was valued at USD 1.02 billion in 2023, expected to reach USD 1.10 billion in 2024, and is projected to grow at a CAGR of 8.23%, to USD 1.77 billion by 2030.

Vertebroplasty and kyphoplasty needles are specialized medical instruments used in minimally invasive procedures to treat vertebral compression fractures often caused by osteoporosis. These needles are pivotal in delivering bone cement into fractured vertebrae, thereby stabilizing the spinal column, alleviating pain, and improving patient mobility. The applications primarily span the healthcare sector, particularly within hospitals and outpatient surgical centers, targeting aging populations prone to osteoporotic fractures. Key growth factors driving the market include the rising incidence of osteoporosis and advancements in minimally invasive spine surgery techniques. Moreover, an aging global population and increasing awareness about spine health are boosting demand.

Opportunities lie in emerging markets with growing healthcare infrastructure and increasing healthcare expenditures. Companies can also capitalize by investing in product development to enhance needle efficiency and safety, or by expanding their geographic footprint. However, the market faces challenges such as the high cost of procedures, potential complications associated with spinal surgeries, and stringent regulatory requirements, which can impede growth.

Innovation can focus on developing cost-effective solutions, such as precision-engineered needles for enhanced accuracy or integrating smart technology to improve procedural outcomes. Research into biodegradable bone cements or bioactive materials could also present new avenues. Competitive differentiation could be achieved by focusing on customization and offering comprehensive service packages, including training for medical professionals.

In terms of market nature, it is moderately competitive with key players continually striving for advanced product offerings and technological conveniences. Companies should also be mindful of shifting regulatory landscapes, particularly concerning safety standards and procedural approvals. Thus, firms should leverage technological advancements and collaborations with healthcare providers to enhance market penetration and clinical outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vertebroplasty & Kyphoplasty Needles Market

The Vertebroplasty & Kyphoplasty Needles Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of spinal injuries among population
  • Ongoing healthcare expenditure across the world
  • Growing awareness on efficiency and stabilization of fracture with the procedure
• Market Restraints
  • High cost of vertebroplasty & kryphoplastry needles
• Market Opportunities
  • Technological advances in vertebroplasty & kryphoplastry needles
  • Emerging collaborations and partnerships among organizations
• Market Challenges
  • Concerns over complications pertinent to cement leakage and fracture of adjacent bone

Porter's Five Forces: A Strategic Tool for Navigating the Vertebroplasty & Kyphoplasty Needles Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vertebroplasty & Kyphoplasty Needles Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vertebroplasty & Kyphoplasty Needles Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vertebroplasty & Kyphoplasty Needles Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vertebroplasty & Kyphoplasty Needles Market

A detailed market share analysis in the Vertebroplasty & Kyphoplasty Needles Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vertebroplasty & Kyphoplasty Needles Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vertebroplasty & Kyphoplasty Needles Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vertebroplasty & Kyphoplasty Needles Market

A strategic analysis of the Vertebroplasty & Kyphoplasty Needles Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vertebroplasty & Kyphoplasty Needles Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, BIOPSYBELL S.R.L., Cardinal Health, Inc., Globus Medical, Inc., IZI Medical Products LLC by Halma PLC, JAYON IMPLANTS Pvt. Ltd., Johnson & Johnson Service, Inc., Laurane Medical LLC, Medtronic PLC, Merit Medical Systems, Inc., Moller Medical GmbH, Stryker Corporation, Suretech Medical Inc, Tecres SPA, and Teknimed.

Market Segmentation & Coverage

This research report categorizes the Vertebroplasty & Kyphoplasty Needles Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Procedure, market is studied across Kyphoplasty Procedures and Vertebroplasty Procedures. The Vertebroplasty Procedures is further studied across Directional Vertebroplasty Needles and Straight Vertebroplasty Needles.
• Based on End-user, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of spinal injuries among population
    • 5.1.1.2. Ongoing healthcare expenditure across the world
    • 5.1.1.3. Growing awareness on efficiency and stabilization of fracture with the procedure
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of vertebroplasty & kryphoplastry needles
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advances in vertebroplasty & kryphoplastry needles
    • 5.1.3.2. Emerging collaborations and partnerships among organizations
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns over complications pertinent to cement leakage and fracture of adjacent bone
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vertebroplasty & Kyphoplasty Needles Market, by Procedure

• 6.1. Introduction
• 6.2. Kyphoplasty Procedures
• 6.3. Vertebroplasty Procedures
  • 6.3.1. Directional Vertebroplasty Needles
  • 6.3.2. Straight Vertebroplasty Needles

7. Vertebroplasty & Kyphoplasty Needles Market, by End-user

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals

8. Americas Vertebroplasty & Kyphoplasty Needles Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Vertebroplasty & Kyphoplasty Needles Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Vertebroplasty & Kyphoplasty Needles Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Becton, Dickinson and Company
• 2. BIOPSYBELL S.R.L.
• 3. Cardinal Health, Inc.
• 4. Globus Medical, Inc.
• 5. IZI Medical Products LLC by Halma PLC
• 6. JAYON IMPLANTS Pvt. Ltd.
• 7. Johnson & Johnson Service, Inc.
• 8. Laurane Medical LLC
• 9. Medtronic PLC
• 10. Merit Medical Systems, Inc.
• 11. Moller Medical GmbH
• 12. Stryker Corporation
• 13. Suretech Medical Inc
• 14. Tecres SPA
• 15. Teknimed